Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice (Q83995787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

Zheng F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Zeng YJ

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Plati AR

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Elliot SJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Berho M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Potier M

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Striker LJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Striker GE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

14 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

507-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16775596%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001578

30 January 2020

exact match

0 references

cites work

NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

The evolving diabetes burden in the United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Glycoxidation and diabetic complications: modern lessons and a warning?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Maillard reaction products in tissue proteins: new products and new perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Angiotensin II and its receptors in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Role of angiotensin II in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Abnormal splicing of the leptin receptor in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Studies in the diabetic mutant mouse. I. Light microscopy and radioautography of pancreatic islets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Differential efficacy of perindopril and enalapril in experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Resistance to glomerulosclerosis in B6 mice disappears after menopause

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021

Standardizing the immunological measurement of advanced glycation endproducts using normal human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001578

7 January 2021